Impairment of T cell immunity by the respiratory syncytial virus: Targeting virulence mechanisms for therapy and prophylaxis

Current Medicinal Chemistry

Volumn 16, Issue 34, 2009, Pages 4609-4625

  Gonzalez P A ^a   Bueno, S M ^a   Riedel, C A ^a,c   Kalergis, A M ^a,b  

^a Pontificia Universidad Católica de Chile   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSIDAD ANDRÉS BELLO   (Chile)

Author keywords

Dendritic cells; Immune evasion; Recombinant bacteria; T cell immunity; Vaccines; Virulence factors

Indexed keywords

BACTERIAL VECTOR; BCG VACCINE; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; RESPIRATORY SYNCYTIAL VIRUS VACCINE; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4; VIRUS VECTOR;

ADAPTIVE IMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG TARGETING; HUMAN; IMMUNOCOMPROMISED PATIENT; LUNG TUBERCULOSIS; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOLECULAR MECHANICS; NONHUMAN; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVIEW; TH1 CELL; TH2 CELL; VIRAL BRONCHIOLITIS; VIRAL GENE DELIVERY SYSTEM; VIRUS INTERFERENCE; VIRUS PATHOGENESIS; VIRUS PNEUMONIA; VIRUS VIRULENCE;

ADAPTIVE IMMUNITY; ANIMALS; CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNITY, INNATE; IMMUNOLOGICAL SYNAPSES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUSES; T-LYMPHOCYTE SUBSETS; VIRAL PROTEINS;

EID: 72449183260     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709789760724     Document Type: Review

References (251)

1. Robinson, R.F. Impact of respiratory syncytial virus in the United States. Am. J. Health. Syst. Pharm., 2008, 65, S3-6.
2. van den Hoogen, B.G.; de Jong, J.C.; Groen, J.; Kuiken, T.; de Groot, R.; Fouchier, R.A.; Osterhaus, A.D. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med., 2001, 7, 719-724
3. Hacking, D.; Hull, J. Respiratory syncytial virus - viral biology and the host response. J. Infect., 2002, 45, 18-24. (Pubitemid 36104802)
4. Patel, J.A.; Nguyen, D.T.; Revai, K.; Chonmaitree, T. Role of respiratory syncytial virus in acute otitis media: implications for vaccine development. Vaccine, 2007, 25, 1683-1689 (Pubitemid 46108199)
5. Thompson, W.W.; Shay, D.K.; Weintraub, E.; Brammer, L.; Cox, N.; Anderson, L.J.; Fukuda, K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA, 2003, 289, 179-186 (Pubitemid 36068705)
6. Shay, D.K.; Holman, R.C.; Roosevelt, G.E.; Clarke, M.J.; Anderson, L.J. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J. Infect. Dis., 2001, 183, 16-22.
7. Ramaswamy, M.; Groskreutz, D.J.; Look, D.C. Recognizing the importance of respiratory syncytial virus in chronic obstructive pulmonary disease. COPD, 2009, 6, 64-75.
8. Mohapatra, S.S.; Boyapalle, S. Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma. Clin. Microbiol. Rev., 2008, 21, 495-504.
9. Thomsen, S.F.; van der Sluis, S.; Stensballe, L.G.; Posthuma, D.; Skytthe, A.; Kyvik, K.O.; Duffy, D.L.; Backer, V.; Bisgaard, H. Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study. Am. J. Respir. Crit. Care Med., 2009, 179, 1091-1097
10. Stensballe, L.G.; Simonsen, J.B.; Thomsen, S.F.; Larsen, A.M.; Lysdal, S.H.; Aaby, P.; Kyvik, K.O.; Skytthe, A.; Backer, V.; Bisgaard, H. The causal direction in the association between respiratory syncytial virus hospitalization and asthma. J. Allergy Clin. Immunol., 2009, 123, 131-137 e1.
11. Valkonen, H.; Waris, M.; Ruohola, A.; Ruuskanen, O.; Heikkinen, T. Recurrent wheezing after respiratory syncytial virus or nonrespiratory syncytial virus bronchiolitis in infancy: a 3-year followup. Allergy, 2009, 64, 1359-1365
12. Sweetman, L.L.; Ng, Y.T.; Butler, I.J.; Bodensteiner, J.B. Neurologic complications associated with respiratory syncytial virus. Pediatr. Neurol., 2005, 32, 307-310 (Pubitemid 40615338)
13. Millichap, J.J.; Wainwright, M.S. Neurological Complications of Respiratory Syncytial Virus Infection: Case Series and Review of Literature. J. Child Neurol., 2009, (epub ahead of print).
14. Seto, M.; Shiomi, M.; Togawa, M.; Lee, S.S.; Yabiku, M.; Sugita, T. [Thirty seven cases of respiratory syncytial virus infection hospitalised and 7 severe cases with apneic attacks]. Kansenshogaku Zasshi, 1994, 68, 226-233
15. Eisenhut, M. Extrapulmonary manifestations of severe respiratory syncytial virus infection--a systematic review. Crit. Care, 2006, 10, R107. (Pubitemid 47086894)
16. Mejias, A.; Chavez-Bueno, S.; Jafri, H.S.; Ramilo, O. Respiratory syncytial virus infections: old challenges and new opportunities. Pediatr. Infect. Dis. J., 2005, 24, S189-96, discussion S196-7.
17. Grayson, M.H.; Holtzman, M.J. Emerging role of dendritic cells in respiratory viral infection. J. Mol. Med., 2007, 85, 1057-1068 (Pubitemid 47476728)
18. Respiratory syncytial virus activity - United States, July 2007-December 2008. MMWR. Morb. Mortal. Wkly. Rep., 2008, 57, 1355-1358
19. Kneyber, M.C.; Brandenburg, A.H.; de Groot, R.; Joosten, K.F.; Rothbarth, P.H.; Ott, A.; Moll, H.A. Risk factors for respiratory syncytial virus associated apnoea. Eur. J. Pediatr., 1998, 157, 331-335
20. Paramore, L.C.; Ciuryla, V.; Ciesla, G.; Liu, L. Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases. Pharmacoeconomics, 2004, 22, 275-284 (Pubitemid 38553698)
21. Bueno, S.M.; Gonzalez, P.A.; Pacheco, R.; Leiva, E.D.; Cautivo, K.M.; Tobar, H.E.; Mora, J.E.; Prado, C.E.; Zuniga, J.P.; Jimenez, J.; Riedel, C.A.; Kalergis, A.M. Host immunity during RSV pathogenesis. Int. Immunopharmacol., 2008, 8, 1320-1329
22. Bennett, B.L.; Garofalo, R.P.; Cron, S.G.; Hosakote, Y.M.; Atmar, R.L.; Macias, C.G.; Piedra, P.A. Immunopathogenesis of respiratory syncytial virus bronchiolitis. J. Infect. Dis., 2007, 195, 1532-1540 (Pubitemid 46717472)
23. Lukacs, N.W.; Smit, J.; Lindell, D.; Schaller, M. Respiratory syncytial virus-induced pulmonary disease and exacerbation of allergic asthma. Contrib. Microbiol., 2007, 14, 68-82.
24. Schaller, M.A.; Kallal, L.E.; Lukacs, N.W. A key role for CC chemokine receptor 1 in T-cell-mediated respiratory inflammation. Am. J. Pathol., 2008, 172, 386-394
25. Welliver, R.C., Sr. The immune response to respiratory syncytial virus infection: friend or foe? Clin. Rev. Allergy Immunol., 2008, 34, 163-173
26. Tregoning, J.S.; Yamaguchi, Y.; Harker, J.; Wang, B.; Openshaw, P.J. The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice. J. Virol., 2008, 82, 4115-4124
27. Harker, J.; Bukreyev, A.; Collins, P.L.; Wang, B.; Openshaw, P.J.; Tregoning, J.S. Virally delivered cytokines alter the immune response to future lung infections. J. Virol., 2007, 81, 13105-13111
28. Becker, Y. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy - a review. Virus Genes, 2006, 33, 235-252 (Pubitemid 44401431)
29. Kristjansson, S.; Bjarnarson, S.P.; Wennergren, G.; Palsdottir, A.H.; Arnadottir, T.; Haraldsson, A.; Jonsdottir, I. Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response. J. Allergy Clin. Immunol., 2005, 116, 805-811 (Pubitemid 41400545)
30. Becker, S.; Soukup, J.M. Airway epithelial cell-induced activation of monocytes and eosinophils in respiratory syncytial viral infection. Immunobiology, 1999, 201, 88-106.
31. Matthews, S.P.; Tregoning, J.S.; Coyle, A.J.; Hussell, T.; Openshaw, P.J. Role of CCL11 in eosinophilic lung disease during respiratory syncytial virus infection. J. Virol., 2005, 79, 2050-2057 (Pubitemid 40204562)
32. Jaovisidha, P.; Peeples, M.E.; Brees, A.A.; Carpenter, L.R.; Moy, J.N. Respiratory syncytial virus stimulates neutrophil degranulation and chemokine release. J. Immunol., 1999, 163, 2816-2820
33. Olszewska-Pazdrak, B.; Pazdrak, K.; Ogra, P.L.; Garofalo, R.P. Respiratory syncytial virus-infected pulmonary epithelial cells induce eosinophil degranulation by a CD18-mediated mechanism. J. Immunol., 1998, 160, 4889-4895 (Pubitemid 28215323)
34. Graham, B.S.; Johnson, T.R.; Peebles, R.S. Immune-mediated disease pathogenesis in respiratory syncytial virus infection. Immunopharmacology, 2000, 48, 237-247 (Pubitemid 30674110)
35. Chang, J.; Braciale, T.J. Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ Tcell memory in the respiratory tract. Nat. Med., 2002, 8, 54-60.
36. Vallbracht, S.; Unsold, H.; Ehl, S. Functional impairment of cytotoxic T cells in the lung airways following respiratory virus infections. Eur. J. Immunol., 2006, 36, 1434-1442 (Pubitemid 43942133)
37. DiNapoli, J.M.; Murphy, B.R.; Collins, P.L.; Bukreyev, A. Impairment of the CD8+ T cell response in lungs following infection with human respiratory syncytial virus is specific to the anatomical site rather than the virus, antigen, or route of infection. Virol. J., 2008, 5, 105.
38. Respiratory syncytial virus activity - United States, 1999-2000 season. MMWR. Morb. Mortal. Wkly. Rep., 2000, 49, 1091-1093
39. Hall, C.B.; Walsh, E.E.; Long, C.E.; Schnabel, K.C. Immunity to and frequency of reinfection with respiratory syncytial virus. J. Infect. Dis., 1991, 163, 693-698
40. Henderson, F.W.; Collier, A.M.; Clyde, W.A., Jr.; Denny, F.W. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N. Engl. J. Med., 1979, 300, 530-534
41. Ogra, P.L. Respiratory syncytial virus: the virus, the disease and the immune response. Paediatr. Respir. Rev., 2004, 5(Suppl A), S119-26.
42. Beem, M. Repeated infections with respiratory syncytial virus. J. Immunol., 1967, 98, 1115-1122
43. Prince, G.A.; Horswood, R.L.; Koenig, D.W.; Chanock, R.M. Antigenic analysis of a putative new strain of respiratory syncytial virus. J. Infect. Dis., 1985, 151, 634-637 (Pubitemid 15102159)
44. Olson, M.R.; Hartwig, S.M.; Varga, S.M. The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia. J. Immunol., 2008, 181, 7958-7968
45. Bueno, S.M.; Gonzalez, P.A.; Cautivo, K.M.; Mora, J.E.; Leiva, E.D.; Tobar, H.E.; Fennelly, G.J.; Eugenin, E.A.; Jacobs, W.R., Jr.; Riedel, C.A.; Kalergis, A.M. Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. Proc. Natl. Acad. Sci. U. S. A., 2008, 105, 20822-20827
46. Zeng, R.; Qi, X.; Gong, W.; Mei, X.; Wei, L.; Ma, C.; Yin, X. Long-lasting balanced immunity and protective efficacy against respiratory syncytial virus in mice induced by a recombinant protein G1F/M2. Vaccine, 2007, 25, 7422-7428 (Pubitemid 47484010)
47. Fu, Y.; He, J.; Zheng, X.; Wu, Q.; Zhang, M.; Wang, X.; Wang, Y.; Xie, C.; Tang, Q.; Wei, W.; Wang, M.; Song, J.; Qu, J.; Zhang, Y.; Hong, T. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice. Biochem. Biophys. Res. Commun., 2009, (epub ahead of print).
48. Castilow, E.M.; Olson, M.R.; Meyerholz, D.K.; Varga, S.M. Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion proteinimmunized mice undergoing challenge infection with respiratory syncytial virus. J. Virol., 2008, 82, 2196-2207
49. Jiang, X.B.; Wang, Z.D.; Zhu, Y.; Zhang, X.L.; Cui, X.F.; Yao, K.; Yin, K.S. Inhibition of CD8+ T lymphocytes attenuates respiratory syncytial virus-enhanced allergic inflammation. Respiration, 2009, 77, 76-84.
50. Yu, J.R.; Kim, S.; Lee, J.B.; Chang, J. Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection. J. Virol., 2008, 82, 2350-2357 (Pubitemid 351293535)
51. Kim, H.W.; Canchola, J.G.; Brandt, C.D.; Pyles, G.; Chanock, R.M.; Jensen, K.; Parrott, R.H. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol., 1969, 89, 422-434
52. Kapikian, A.Z.; Mitchell, R.H.; Chanock, R.M.; Shvedoff, R.A.; Stewart, C.E. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol., 1969, 89, 405-421
53. Fulginiti, V.A.; Eller, J.J.; Sieber, O.F.; Joyner, J.W.; Minamitani, M.; Meiklejohn, G. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am. J. Epidemiol., 1969, 89, 435-448
54. Moghaddam, A.; Olszewska, W.; Wang, B.; Tregoning, J.S.; Helson, R.; Sattentau, Q.J.; Openshaw, P.J. A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines. Nat. Med., 2006, 12, 905-907
55. Delgado, M.F.; Coviello, S.; Monsalvo, A.C.; Melendi, G.A.; Hernandez, J.Z.; Batalle, J.P.; Diaz, L.; Trento, A.; Chang, H.Y.; Mitzner, W.; Ravetch, J.; Melero, J.A.; Irusta, P.M.; Polack, F.P. Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat. Med., 2009, 15, 34-41.
56. Stark, J.M.; McDowell, S.A.; Koenigsknecht, V.; Prows, D.R.; Leikauf, J.E.; Le Vine, A.M.; Leikauf, G.D. Genetic susceptibility to respiratory syncytial virus infection in inbred mice. J. Med. Virol., 2002, 67, 92-100. (Pubitemid 34260079)
57. Mejias, A.; Chavez-Bueno, S.; Gomez, A.M.; Somers, C.; Estripeaut, D.; Torres, J.P.; Jafri, H.S.; Ramilo, O. Respiratory syncytial virus persistence: evidence in the mouse model. Pediatr. Infect. Dis. J., 2008, 27, S60-2.
58. Chavez-Bueno, S.; Mejias, A.; Gomez, A.M.; Olsen, K.D.; Rios, A.M.; Fonseca-Aten, M.; Ramilo, O.; Jafri, H.S. Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model. Virol. J., 2005, 2, 46.
59. Dakhama, A.; Lee, Y.M.; Ohnishi, H.; Jing, X.; Balhorn, A.; Takeda, K.; Gelfand, E.W. Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice. J. Allergy Clin. Immunol., 2009, 123, 138-145 e5.
60. Singleton, R.; Etchart, N.; Hou, S.; Hyland, L. Inability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody responses. J. Virol., 2003, 77, 11303-11311 (Pubitemid 37271629)
61. Chang, J.; Srikiatkhachorn, A.; Braciale, T.J. Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection. J. Immunol., 2001, 167, 4254-4260 (Pubitemid 32954299)
62. Lukens, M.V.; Claassen, E.A.; de Graaff, P.M.; van Dijk, M.E.; Hoogerhout, P.; Toebes, M.; Schumacher, T.N.; van der Most, R.G.; Kimpen, J.L.; van Bleek, G.M. Characterization of the CD8+ T cell responses directed against respiratory syncytial virus during primary and secondary infection in C57BL/6 mice. Virology, 2006, 352, 157-168 (Pubitemid 44142692)
63. Eckardt-Michel, J.; Lorek, M.; Baxmann, D.; Grunwald, T.; Keil, G.M.; Zimmer, G. The fusion protein of respiratory syncytial virus triggers p53-dependent apoptosis. J. Virol., 2008, 82, 3236-3249
64. Varga, S.M.; Wang, X.; Welsh, R.M.; Braciale, T.J. Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4(+) T cells. Immunity, 2001, 15, 637-646
65. Hancock, G.E.; Tebbey, P.W.; Scheuer, C.A.; Pryharski, K.S.; Heers, K.M.; LaPierre, N.A. Immune responses to the nonglycosylated ectodomain of respiratory syncytial virus attachment glycoprotein mediate pulmonary eosinophilia in inbred strains of mice with different MHC haplotypes. J. Med. Virol., 2003, 70, 301-308
66. Shingai, M.; Azuma, M.; Ebihara, T.; Sasai, M.; Funami, K.; Ayata, M.; Ogura, H.; Tsutsumi, H.; Matsumoto, M.; Seya, T. Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction. Int. Immunol., 2008, 20, 1169-1180
67. Bembridge, G.P.; Lopez, J.A.; Bustos, R.; Melero, J.A.; Cook, R.; Mason, H.; Taylor, G. Priming with a secreted form of the fusion protein of respiratory syncytial virus (RSV) promotes interleukin-4 (IL-4) and IL-5 production but not pulmonary eosinophilia following RSV challenge. J. Virol., 1999, 73, 10086-10094
68. Kurt-Jones, E.A.; Popova, L.; Kwinn, L.; Haynes, L.M.; Jones, L.P.; Tripp, R.A.; Walsh, E.E.; Freeman, M.W.; Golenbock, D.T.; Anderson, L.J.; Finberg, R.W. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol, 2000, 1, 398-401.
69. Awomoyi, A.A.; Rallabhandi, P.; Pollin, T.I.; Lorenz, E.; Sztein, M.B.; Boukhvalova, M.S.; Hemming, V.G.; Blanco, J.C.; Vogel, S.N. Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children. J. Immunol., 2007, 179, 3171-3177
70. Tulic, M.K.; Hurrelbrink, R.J.; Prele, C.M.; Laing, I.A.; Upham, J.W.; Le Souef, P.; Sly, P.D.; Holt, P.G. TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide. J. Immunol., 2007, 179, 132-140
71. Burke, S.M.; Issekutz, T.B.; Mohan, K.; Lee, P.W.; Shmulevitz, M.; Marshall, J.S. Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism. Blood, 2008, 111, 5467-5476
72. Bataki, E.L.; Evans, G.S.; Everard, M.L. Respiratory syncytial virus and neutrophil activation. Clin. Exp. Immunol., 2005, 140, 470-477 (Pubitemid 40813957)
73. Yasui, K.; Baba, A.; Iwasaki, Y.; Kubo, T.; Aoyama, K.; Mori, T.; Yamazaki, T.; Kobayashi, N.; Ishiguro, A. Neutrophil-mediated inflammation in respiratory syncytial viral bronchiolitis. Pediatr. Int., 2005, 47, 190-195 (Pubitemid 40545424)
74. Castro, S.M.; Guerrero-Plata, A.; Suarez-Real, G.; Adegboyega, P.A.; Colasurdo, G.N.; Khan, A.M.; Garofalo, R.P.; Casola, A. Antioxidant treatment ameliorates respiratory syncytial virus-induced disease and lung inflammation. Am. J. Respir. Crit. Care Med., 2006, 174, 1361-1369 (Pubitemid 44913038)
75. Oshansky, C.M.; Krunkosky, T.M.; Barber, J.; Jones, L.P.; Tripp, R.A. Respiratory syncytial virus proteins modulate suppressors of cytokine signaling 1 and 3 and the type I interferon response to infection by a toll-like receptor pathway. Viral Immunol., 2009, 22, 147-161
76. Rudd, B.D.; Burstein, E.; Duckett, C.S.; Li, X.; Lukacs, N.W. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J. Virol., 2005, 79, 3350-3357
77. Murawski, M.R.; Bowen, G.N.; Cerny, A.M.; Anderson, L.J.; Haynes, L.M.; Tripp, R.A.; Kurt-Jones, E.A.; Finberg, R.W. Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J. Virol., 2009, 83, 1492-1500
78. Becker, S.; Reed, W.; Henderson, F.W.; Noah, T.L. RSV infection of human airway epithelial cells causes production of the betachemokine RANTES. Am. J. Physiol., 1997, 272, L512-20.
79. Chung, H.L.; Kim, S.G. RANTES may be predictive of later recurrent wheezing after respiratory syncytial virus bronchiolitis in infants. Ann. Allergy Asthma. Immunol., 2002, 88, 463-467
80. Sheeran, P.; Jafri, H.; Carubelli, C.; Saavedra, J.; Johnson, C.; Krisher, K.; Sanchez, P.J.; Ramilo, O. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr. Infect. Dis. J., 1999, 18, 115-122 (Pubitemid 29101883)
81. John, A.E.; Berlin, A.A.; Lukacs, N.W. Respiratory syncytial virus-induced CCL5/RANTES contributes to exacerbation of allergic airway inflammation. Eur. J. Immunol., 2003, 33, 1677-1685
82. Tekkanat, K.K.; Maassab, H.; Miller, A.; Berlin, A.A.; Kunkel, S.L.; Lukacs, N.W. RANTES (CCL5) production during primary respiratory syncytial virus infection exacerbates airway disease. Eur. J. Immunol., 2002, 32, 3276-3284 (Pubitemid 35414885)
83. Graham, B.S.; Bunton, L.A.; Wright, P.F.; Karzon, D.T. Reinfection of mice with respiratory syncytial virus. J. Med. Virol., 1991, 34, 7-13.
84. Siezen, C.L.; Bont, L.; Hodemaekers, H.M.; Ermers, M.J.; Doornbos, G.; Van't Slot, R.; Wijmenga, C.; Houwelingen, H.C.; Kimpen, J.L.; Kimman, T.G.; Hoebee, B.; Janssen, R. Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes. Pediatr. Infect. Dis. J., 2009, 28, 333-335
85. Janssen, R.; Bont, L.; Siezen, C.L.; Hodemaekers, H.M.; Ermers, M.J.; Doornbos, G.; van 't Slot, R.; Wijmenga, C.; Goeman, J.J.; Kimpen, J.L.; van Houwelingen, H.C.; Kimman, T.G.; Hoebee, B. Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. J. Infect. Dis., 2007, 196, 826-834
86. Chung, H.L.; Park, H.J.; Kim, S.Y.; Kim, S.G. Age-related difference in immune responses to respiratory syncytial virus infection in young children. Pediatr. Allergy Immunol., 2007, 18, 94-99 (Pubitemid 46333727)
87. Dakhama, A.; Park, J.W.; Taube, C.; Joetham, A.; Balhorn, A.; Miyahara, N.; Takeda, K.; Gelfand, E.W. The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production. J. Immunol., 2005, 175, 1876-1883
88. Culley, F.J.; Pollott, J.; Openshaw, P.J. Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J. Exp. Med., 2002, 196, 1381-1386
89. Lee, Y.M.; Miyahara, N.; Takeda, K.; Prpich, J.; Oh, A.; Balhorn, A.; Joetham, A.; Gelfand, E.W.; Dakhama, A. IFN-gamma production during initial infection determines the outcome of reinfection with respiratory syncytial virus. Am. J. Respir. Crit. Care Med., 2008, 177, 208-218
90. Singleton, R.; Etchart, N.; Hou, S.; Hyland, L. Inability To Evoke a Long-Lasting Protective Immune Response to Respiratory Syncytial Virus Infection in Mice Correlates with Ineffective Nasal Antibody Responses. J. Virol., 2003, 77, 11303-11311. (Pubitemid 37271629)
91. Hussell, T.; Spender, L.C.; Georgiou, A.; O'Garra, A.; Openshaw, P.J. Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus. J. Gen. Virol., 1996, 77 (Pt 10), 2447-2455 (Pubitemid 26348366)
92. Connors, M.; Kulkarni, A.B.; Firestone, C.Y.; Holmes, K.L.; Morse 3rd, H.C.; Sotnikov, A.V.; Murphy, B.R. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. J. Virol., 1992, 66, 7444-7451.
93. Varga, S.M.; Wang, X.; Welsh, R.M.; Braciale, T.J. Immunopathology in RSV Infection Is Mediated by a Discrete Oligoclonal Subset of Antigen-Specific CD4+ T Cells. Immunity, 2001, 15, 637-646.
94. Tsutsumi, H.; Sone, S.; Takeuchi, R.; Osaki, M.; Chiba, S. Systemic and local immune responses of four cases with lower respiratory tract illness due to reinfection with respiratory syncytial virus. J. Infect., 1997, 35, 189-192
95. McGill, A.; Greensill, J.; Marsh, R.; Craft, A.W.; Toms, G.L. Detection of human respiratory syncytial virus genotype specific antibody responses in infants. J. Med. Virol., 2004, 74, 492.
96. Bukreyev, A.; Yang, L.; Fricke, J.; Cheng, L.; Ward, J.M.; Murphy, B.R.; Collins, P.L. The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes. J. Virol., 2008, 82, 12191-12204
97. Braciale, T.J. Respiratory Syncytial Virus and T Cells: Interplay between the Virus and the Host Adaptive Immune System. Proc. Am. Thorac. Soc., 2005, 2, 141-146.
98. Bont, L.; Versteegh, J.; Swelsen, W.T.; Heijnen, C.J.; Kavelaars, A.; Brus, F.; Draaisma, J.M.; Pekelharing-Berghuis, M.; van Diemen-Steenvoorde, R.A.; Kimpen, J.L. Natural reinfection with respiratory syncytial virus does not boost virus-specific T-cell immunity. Pediatr. Res., 2002, 52, 363-367
99. Rothoeft, T.; Fischer, K.; Zawatzki, S.; Schulz, V.; Schauer, U.; Korner Rettberg, C. Differential response of human naive and memory/effector T cells to dendritic cells infected by respiratory syncytial virus. Clin. Exp. Immunol., 2007, 150, 263-273 (Pubitemid 47609573)
100. Liu, B.; Woltman, A.M.; Janssen, H.L.; Boonstra, A. Modulation of dendritic cell function by persistent viruses. J. Leukoc. Biol., 2009, 85, 205-214
101. Powers, C.; DeFilippis, V.; Malouli, D.; Fruh, K. Cytomegalovirus immune evasion. Curr. Top Microbiol. Immunol., 2008, 325, 333-359
102. Schneider-Schaulies, S.; Schneider-Schaulies, J. Measles virus-induced immunosuppression. Curr. Top Microbiol. Immunol., 2009, 330, 243-269
103. Srikiatkhachorn, A.; Braciale, T.J. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J. Exp. Med., 1997, 186, 421-432
104. Chang, J.; Choi, S.Y.; Jin, H.T.; Sung, Y.C.; Braciale, T.J. Improved effector activity and memory CD8 T cell development by IL-2 expression during experimental respiratory syncytial virus infection. J. Immunol., 2004, 172, 503-508
105. Beyer, M.; Bartz, H.; Horner, K.; Doths, S.; Koerner-Rettberg, C.; Schwarze, J. Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection. J. Allergy Clin. Immunol., 2004, 113, 127-133 (Pubitemid 38096172)
106. Bucks, C.M.; Norton, J.A.; Boesteanu, A.C.; Mueller, Y.M.; Katsikis, P.D. Chronic antigen stimulation alone is sufficient to drive CD8+ T cell exhaustion. J Immunol, 2009, 182, 6697-6708
107. Mueller, S.N.; Ahmed, R. High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proc. Natl. Acad. Sci. U. S. A., 2009, 106, 8623-8628
108. Boasso, A.; Shearer, G.M. Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin. Immunol., 2008, 126, 235-242
109. Chang, J.; Braciale, T.J. Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ Tcell memory in the respiratory tract. Nat. Med., 2002, 8, 54-60.
110. Ostler, T.; Pircher, H.; Ehl, S. "Bystander" recruitment of systemic memory T cells delays the immune response to respiratory virus infection. Eur. J. Immunol., 2003, 33, 1839-1848 (Pubitemid 37120855)
111. Moore, M.L.; Peebles, R.S Jr. Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics. Pharmacol. The., 2006, 112, 405-424
112. Domachowske, J.B.; Bonville, C.A.; Rosenberg, H.F. Animal models for studying respiratory syncytial virus infection and its long term effects on lung function. Pediatr. Infect. Dis. J., 2004, 23, S228-34.
113. van Benten, I.J.; van Drunen, C.M.; Koevoet, J.L.; Koopman, L.P.; Hop, W.C.; Osterhaus, A.D.; Neijens, H.J.; Fokkens, W.J. Reduced nasal IL-10 and enhanced TNFalpha responses during rhinovirus and RSV-induced upper respiratory tract infection in atopic and non-atopic infants. J. Med. Virol., 2005, 75, 348-357
114. Lindemans, C.A.; Kimpen, J.L.L.; Luijk, B.; Heidema, J.; Kanters, D.; van der Ent, C.K.; Koenderman, L. Systemic eosinophil response induced by respiratory syncytial virus. Clin. Exper. Immunol., 2006, 144, 409-417. (Pubitemid 43799923)
115. Byeon, J.H.; Lee, J.C.; Choi, I.S.; Yoo, Y.; Park, S.H.; Choung, J.T. Comparison of cytokine responses in nasopharyngeal aspirates from children with viral lower respiratory tract infections. Acta Paediatr., 2009, 98, 725-730
116. Liu, J.; Ruckwardt, T.J.; Chen, M.; Johnson, T.R.; Graham, B.S. Characterization of Respiratory Syncytial Virus M- and M2-Specific CD4 T Cells in a Murine Model. J. Virol., 2009, (epub ahead of print).
117. Tasker, L.; Lindsay, R.W.; Clarke, B.T.; Cochrane, D.W.; Hou, S. Infection of mice with respiratory syncytial virus during neonatal life primes for enhanced antibody and T cell responses on secondary challenge. Clin. Exp. Immunol., 2008, 153, 277-288 (Pubitemid 351989153)
118. Culley, F.J.; Pennycook, A.M.; Tregoning, J.S.; Hussell, T.; Openshaw, P.J. Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology. J. Virol., 2006, 80, 4521-4527
119. Monick, M.M.; Powers, L.S.; Hassan, I.; Groskreutz, D.; Yarovinsky, T.O.; Barrett, C.W.; Castilow, E.M.; Tifrea, D.; Varga, S.M.; Hunninghake, G.W. Respiratory syncytial virus synergizes with Th2 cytokines to induce optimal levels of TARC/CCL17. J. Immunol., 2007, 179, 1648-1658
120. Bukreyev, A.; Belyakov, I.M.; Prince, G.A.; Yim, K.C.; Harris, K.K.; Berzofsky, J.A.; Collins, P.L. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus. J. Virol., 2005, 79, 9515-9526
121. Khan, S.H.; Park, S.S.; Sirajuddin, I.A.; Grayson, M.H. Respiratory virus and asthma: the role of immunoglobulin E. Clin. Ther., 2008, 30 Spec No, 1017-1024
122. Dakhama, A.; Park, J.W.; Taube, C.; Chayama, K.; Balhorn, A.; Joetham, A.; Wei, X.D.; Fan, R.H.; Swasey, C.; Miyahara, N.; Kodama, T.; Alvarez, A.; Takeda, K.; Gelfand, E.W. The role of virus- specific immunoglobulin E in airway hyperresponsiveness. Am. J. Respir. Crit. Care Med., 2004, 170, 952-959 (Pubitemid 39425690)
123. Olson, M.R.; Varga, S.M. CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease. J. Immunol., 2007, 179, 5415-5424
124. de Jong, E.C.; Vieira, P.L.; Kalinski, P.; Schuitemaker, J.H.; Tanaka, Y.; Wierenga, E.A.; Yazdanbakhsh, M.; Kapsenberg, M.L. Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cellpolarizing signals. J. Immunol., 2002, 168, 1704-1709
125. Kidd P. Th1/Th2 Balance: The Hypothesis, its Limitations, and Implications for Health and Disease. Altern Med. Rev., 2003, 8, 223-246. (Pubitemid 37099886)
126. Gonzalez, P.A.; Prado, C.E.; Leiva, E.D.; Carreno, L.J.; Bueno, S.M.; Riedel, C.A.; Kalergis, A.M. Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells. Proc. Natl. Acad. Sci. U. S. A., 2008, 105, 14999-15004
127. Thorburn, K.; Harigopal, S.; Reddy, V.; Taylor, N.; van Saene, H.K. High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. Thorax, 2006, 61, 611-615
128. Korppi, M.; Leinonen, M.; Koskela, M.; Makela, P.H.; Launiala, K. Bacterial coinfection in children hospitalized with respiratory syncytial virus infections. Pediatr. Infect. Dis. J., 1989, 8, 687-692 (Pubitemid 19253584)
129. Johnson, T.R.; Johnson, J.E.; Roberts, S.R.; Wertz, G.W.; Parker, R.A.; Graham, B.S. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge. J. Virol., 1998, 72, 2871-2880
130. Varga, S.M.; Wissinger, E.L.; Braciale, T.J. The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses. J. Immunol., 2000, 165, 6487-6495
131. Tripp, R.A.; Jones, L.P.; Haynes, L.M.; Zheng, H.; Murphy, P.M.; Anderson, L.J. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat. Immunol., 2001, 2, 732-738 (Pubitemid 32747163)
132. Stievano, L.; Piovan, E.; Amadori, A. C and CX3C chemokines: cell sources and physiopathological implications. Crit. Rev. Immunol., 2004, 24, 205-228
133. Harcourt, J.; Alvarez, R.; Jones, L.P.; Henderson, C.; Anderson, L.J.; Tripp, R.A. Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses. J. Immunol., 2006, 176, 1600-1608
134. Li, X.Q.; Fu, Z.F.; Alvarez, R.; Henderson, C.; Tripp, R.A. Respiratory syncytial virus (RSV) infects neuronal cells and processes that innervate the lung by a process involving RSV G protein. J. Virol., 2006, 80, 537-540
135. Gabuzda, D.; Wang, J. Chemokine receptors and virus entry in the central nervous system. J. Neurovirol., 1999, 5, 643-658 (Pubitemid 30032090)
136. Hatori, K.; Nagai, A.; Heisel, R.; Ryu, J.K.; Kim, S.U. Fractalkine and fractalkine receptors in human neurons and glial cells. J. Neurosci. Res., 2002, 69, 418-426 (Pubitemid 34809490)
137. Segal, B.M. The role of natural killer cells in curbing neuroinflammation. J. Neuroimmunol., 2007, 191, 2-7. (Pubitemid 350060993)
138. Geissmann, F.; Jung, S.; Littman, D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity, 2003, 19, 71-82.
139. Niess, J.H.; Brand, S.; Gu, X.; Landsman, L.; Jung, S.; McCormick, B.A.; Vyas, J.M.; Boes, M.; Ploegh, H.L.; Fox, J.G.; Littman, D.R.; Reinecker, H.C. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science, 2005, 307, 254-258
140. Dodd, J.; Riffault, S.; Kodituwakku, J.S.; Hayday, A.C.; Openshaw, P.J. Pulmonary V gamma 4+ gamma delta T cells have proinflammatory and antiviral effects in viral lung disease. J. Immunol., 2009, 182, 1174-1181
141. de Graaff, P.M.; de Jong, E.C.; van Capel, T.M.; van Dijk, M.E.; Roholl, P.J.; Boes, J.; Luytjes, W.; Kimpen, J.L.; van Bleek, G.M. Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells. J. Immunol., 2005, 175, 5904-5911
142. Ruckwardt, T.J.; Bonaparte, K.L.; Nason, M.C.; Graham, B.S. Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities. J. Virol., 2009, 83, 3019-3028
143. Chi, B.; Dickensheets, H.L.; Spann, K.M.; Alston, M.A.; Luongo, C.; Dumoutier, L.; Huang, J.; Renauld, J.C.; Kotenko, S.V.; Roederer, M.; Beeler, J.A.; Donnelly, R.P.; Collins, P.L.; Rabin, R.L. Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus. J. Virol., 2006, 80, 5032-5040
144. Schlender, J.; Walliser, G.; Fricke, J.; Conzelmann, K.K. Respiratory syncytial virus fusion protein mediates inhibition of mitogen-induced T-cell proliferation by contact. J. Virol., 2002, 76, 1163-1170
145. Monks, C.R.; Freiberg, B.A.; Kupfer, H.; Sciaky, N.; Kupfer, A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature, 1998, 395, 82-86 (Pubitemid 28420234)
146. Grakoui, A.; Bromley, S.K.; Sumen, C.; Davis, M.M.; Shaw, A.S.; Allen, P.M.; Dustin, M.L. The immunological synapse: a molecular machine controlling T cell activation. Science, 1999, 285, 221-227 (Pubitemid 29329988)
147. Dustin, M.L. The cellular context of T cell signaling. Immunity, 2009, 30, 482-492
148. Gonzalez, P.A.; Carreno, L.J.; Figueroa, C.A.; Kalergis, A.M. Modulation of immunological synapse by membrane-bound and soluble ligands. Cytokine Growth Factor Rev., 2007, 18, 19-31. (Pubitemid 46401428)
149. Iruretagoyena, M.I.; Wiesendanger, M.; Kalergis, A.M. The dendritic cell-T cell synapse as a determinant of autoimmune pathogenesis. Curr. Pharm. Des., 2006, 12, 131-147
150. Depoil, D.; Zaru, R.; Guiraud, M.; Chauveau, A.; Harriague, J.; Bismuth, G.; Utzny, C.; Muller, S.; Valitutti, S. Immunological synapses are versatile structures enabling selective T cell polarization. Immunity, 2005, 22, 185-194 (Pubitemid 40255710)
151. Barcia, C.; Thomas, C.E.; Curtin, J.F.; King, G.D.; Wawrowsky, K.; Candolfi, M.; Xiong, W.D.; Liu, C.; Kroeger, K.; Boyer, O.; Kupiec-Weglinski, J.; Klatzmann, D.; Castro, M.G.; Lowenstein, P.R. In vivo mature immunological synapses forming SMACs mediate clearance of virally infected astrocytes from the brain. J. Exp. Med., 2006, 203, 2095-2107 (Pubitemid 44352231)
152. Thoulouze, M.I.; Sol-Foulon, N.; Blanchet, F.; Dautry-Varsat, A.; Schwartz, O.; Alcover, A. Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse. Immunity, 2006, 24, 547-561 (Pubitemid 43728159)
153. Shishkova, Y.; Harms, H.; Krohne, G.; Avota, E.; Schneider-Schaulies, S. Immune synapses formed with measles virus-infected dendritic cells are unstable and fail to sustain T cell activation. Cell Microbiol., 2007, 9, 1974-1986 (Pubitemid 47087088)
154. Cho, N.H.; Feng, P.; Lee, S.H.; Lee, B.S.; Liang, X.; Chang, H.; Jung, J.U. Inhibition of T cell receptor signal transduction by tyrosine kinase-interacting protein of Herpesvirus saimiri. J. Exp. Med., 2004, 200, 681-687
155. Muller, N.; Avota, E.; Schneider-Schaulies, J.; Harms, H.; Krohne, G.; Schneider-Schaulies, S. Measles virus contact with T cells impedes cytoskeletal remodeling associated with spreading, polarization, and CD3 clustering. Traffic, 2006, 7, 849-858 (Pubitemid 43871775)
156. Haller, C.; Rauch, S.; Fackler, O.T. HIV-1 Nef Employs Two Distinct Mechanisms to Modulate Lck Subcellular Localization and TCR Induced Actin Remodeling. PLoS ONE, 2007, 2, e1212.
157. Boogaard, I.; van Oosten, M.; van Rijt, L.S.; Muskens, F.; Kimman, T.G.; Lambrecht, B.N.; Buisman, A.M. Respiratory syncytial virus differentially activates murine myeloid and plasmacytoid dendritic cells. Immunology, 2007, 122, 65-72.
158. Guerrero-Plata, A.; Casola, A.; Suarez, G.; Yu, X.; Spetch, L.; Peeples, M.E.; Garofalo, R.P. Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus. Am. J. Respir. Cell Mol. Biol., 2006, 34, 320-329 (Pubitemid 43320713)
159. Bartz, H.; Turkel, O.; Hoffjan, S.; Rothoeft, T.; Gonschorek, A.; Schauer, U. Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon-gamma in naive T cells. Immunology, 2003, 109, 49-57. (Pubitemid 36577974)
160. Tobar, J.A.; Gonzalez, P.A.; Kalergis, A.M. Salmonella escape from antigen presentation can be overcome by targeting bacteria to Fc gamma receptors on dendritic cells. J. Immunol., 2004, 173, 4058-4065
161. Al-Younes, H.M.; Rudel, T.; Meyer, T.F. Characterization and intracellular trafficking pattern of vacuoles containing Chlamydia pneumoniae in human epithelial cells. Cell Microbiol., 1999, 1, 237-247
162. Bueno, S.M.; González, P.A.; Carreño, L.J.; Tobar, J.A.; Mora, G.C.; Pereda, C.J.; Salazar-Onfray, F.; Kalergis, A.M. The capacity of Salmonella to survive inside dendritic cells and prevent antigen presentation to T cells is host specific. Immunology, 2008, 124, 522-533 (Pubitemid 351962548)
163. Sturgill-Koszycki, S.; Schlesinger, P.H.; Chakraborty, P.; Haddix, P.L.; Collins, H.L.; Fok, A.K.; Allen, R.D.; Gluck, S.L.; Heuser, J.; Russell, D.G. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science, 1994, 263, 678-681 (Pubitemid 24076294)
164. Gavioli, R.; Gallerani, E.; Fortini, C.; Fabris, M.; Bottoni, A.; Canella, A.; Bonaccorsi, A.; Marastoni, M.; Micheletti, F.; Cafaro, A.; Rimessi, P.; Caputo, A.; Ensoli, B. HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity. J. Immunol., 2004, 173, 3838-3843 (Pubitemid 39280746)
165. Hu, Z.; Zhang, Z.; Doo, E.; Coux, O.; Goldberg, A.L.; Liang, T.J. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J. Virol., 1999, 73, 7231-7240
166. Zhang, M.; Coffino, P. Repeat sequence of Epstein-Barr virus-encoded nuclear antigen 1 protein interrupts proteasome substrate processing. J. Biol. Chem., 2004, 279, 8635-8641 (Pubitemid 38295918)
167. Moutaftsi, M.; Mehl, A.M.; Borysiewicz, L.K.; Tabi, Z. Human cytomegalovirus inhibits maturation and impairs function of monocyte- derived dendritic cells. Blood, 2002, 99, 2913-2921 (Pubitemid 34525381)
168. Means, R.E.; Ishido, S.; Alvarez, X.; Jung, J.U. Multiple endocytic trafficking pathways of MHC class I molecules induced by a Herpesvirus protein. EMBO J., 2002, 21, 1638-1649
169. Kasper, M.R.; Roeth, J.F.; Williams, M.; Filzen, T.M.; Fleis, R.I.; Collins, K.L. HIV-1 Nef disrupts antigen presentation early in the secretory pathway. J. Biol. Chem., 2005, 280, 12840-12848 (Pubitemid 40491105)
170. Neumann, J.; Eis-Hubinger, A.M.; Koch, N. Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion. J. Immunol., 2003, 171, 3075-3083 (Pubitemid 37093531)
171. Park, B.; Kim, Y.; Shin, J.; Lee, S.; Cho, K.; Fruh, K.; Ahn, K. Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. Immunity, 2004, 20, 71-85. (Pubitemid 38134295)
172. Lukens, M.V.; Kruijsen, D.; Coenjaerts, F.E.; Kimpen, J.L.; van Bleek, G.M. Respiratory Syncytial Virus induced activation and migration of respiratory dendritic cells and subsequent antigen presentation in the lung draining lymph node. J. Virol., 2009.
173. Smit, J.J.; Lindell, D.M.; Boon, L.; Kool, M.; Lambrecht, B.N.; Lukacs, N.W. The balance between plasmacytoid DC versus conventional DC determines pulmonary immunity to virus infections. PLoS ONE, 2008, 3, e1720.
174. Lee, S.; Miller, S.A.; Wright, D.W.; Rock, M.T.; Crowe, J.E., Jr. Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection. J. Virol., 2007, 81, 2349-2358
175. Rutigliano, J.A.; Rock, M.T.; Johnson, A.K.; Crowe, J.E., Jr.; Graham, B.S. Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus. Virology, 2005, 337, 335-343
176. Heidema, J.; de Bree, G.J.; De Graaff, P.M.; van Maren, W.W.; Hoogerhout, P.; Out, T.A.; Kimpen, J.L.; van Bleek, G.M. Human CD8(+) T cell responses against five newly identified respiratory syncytial virus-derived epitopes. J. Gen. Virol., 2004, 85, 2365-2374
177. Perrin-Cocon, L.; Agaugue, S.; Diaz, O.; Vanbervliet, B.; Dollet, S.; Guironnet-Paquet, A.; Andre, P.; Lotteau, V. Th1 disabled function in response to TLR4 stimulation of monocyte-derived DC from patients chronically-infected by hepatitis C virus. PLoS ONE, 2008, 3, e2260.
178. Chang, W.L.; Baumgarth, N.; Yu, D.; Barry, P.A. Human cytomegalovirus- encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality. J. Virol., 2004, 78, 8720-8731
179. Hussell, T.; Baldwin, C.J.; O'Garra, A.; Openshaw, P.J. CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur. J. Immunol., 1997, 27, 3341-3349
180. Rudd, B.D.; Luker, G.D.; Luker, K.E.; Peebles, R.S.; Lukacs, N.W. Type I interferon regulates respiratory virus infected dendritic cell maturation and cytokine production. Viral. Immunol., 2007, 20, 531-540
181. Guerrero-Plata, A.; Kolli, D.; Hong, C.; Casola, A.; Garofalo, R.P. Subversion of pulmonary dendritic cell function by paramyxovirus infections. J. Immunol., 2009, 182, 3072-3083
182. Wang, H.; Peters, N.; Schwarze, J. Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection. J. Immunol., 2006, 177, 6263-6270 (Pubitemid 44628844)
183. Mescher M.F.; Curtsinger J.M.; Agarwal P.; Casey K.A.; Gerner M.; Hammerbeck C.D.; Popescu F.; Xiao Z. Signals required for programming effector and memory development by CD8+ T cells. Immunol. Rev., 2006, 211, 81-92. (Pubitemid 43882963)
184. Jewell N.A.; Vaghefi N.; Mertz S.E.; Akter P.; Peebles R.S.Jr.; Bakaletz L.O.; Durbin R.K.; Flano E.; J.E., D. Differential Type I Interferon Induction by Respiratory Syncytial Virus and Influenza A Virus In vivo. J. Virol., 2007, 81, 9790-9800.
185. Morrow, G.; Slobedman, B.; Cunningham, A.L.; Abendroth, A. Varicella-zoster virus productively infects mature dendritic cells and alters their immune function. J. Virol., 2003, 77, 4950-4959 (Pubitemid 36402843)
186. Sun, P.; Celluzzi, C.M.; Marovich, M.; Subramanian, H.; Eller, M.; Widjaja, S.; Palmer, D.; Porter, K.; Sun, W.; Burgess, T. CD40 ligand enhances dengue viral infection of dendritic cells: a possible mechanism for T cell-mediated immunopathology. J. Immunol., 2006, 177, 6497-6503 (Pubitemid 44628869)
187. Benedict, C.A.; Loewendorf, A.; Garcia, Z.; Blazar, B.R.; Janssen, E.M. Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway. J. Immunol., 2008, 180, 4836-4847
188. Lazar-Molnar, E.; Gacser, A.; Freeman, G.J.; Almo, S.C.; Nathenson, S.G.; Nosanchuk, J.D. The PD-1/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma capsulatum. Proc. Natl. Acad. Sci. U. S. A., 2008, 105, 2658-2663
189. Villablanca, E.J.; Russo, V.; Mora, J.R. Dendritic cell migration and lymphocyte homing imprinting. Histol. Histopathol., 2008, 23, 897-910.
190. Randolph, G.J.; Angeli, V.; Swartz, M.A. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev. Immunol., 2005, 5, 617-628
191. Lateef, Z.; Fleming, S.; Halliday, G.; Faulkner, L.; Mercer, A.; Baird, M. Orf virus-encoded interleukin-10 inhibits maturation, antigen presentation and migration of murine dendritic cells. J. Gen. Virol., 2003, 84, 1101-1109 (Pubitemid 36592602)
192. Cicinnati, V.R.; Kang, J.; Sotiropoulos, G.C.; Hilgard, P.; Frilling, A.; Broelsch, C.E.; Gerken, G.; Beckebaum, S. Altered chemotactic response of myeloid and plasmacytoid dendritic cells from patients with chronic hepatitis C: role of alpha interferon. J. Gen. Virol., 2008, 89, 1243-1253
193. Gill M.A.; Palucka A.K.; Barton T.; Ghaffar F.; Jafri H.; Banchereau J.; O., R. Mobilization of Plasmacytoid and Myeloid Dendritic Cells to Mucosal Sites in Children with Respiratory Syncytial Virus and Other Viral Respiratory Infections. J. Infect. Dis., 2005, 1991, 1105-1115.
194. Smit, J.J.; Rudd, B.D.; Lukacs, N.W. Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J. Exp. Med., 2006, 203, 1153-1159
195. Wang, H.; Peters, N.; Laza-Stanca, V.; Nawroly, N.; Johnston, S.L.; Schwarze, J. Local CD11c+ MHC class II- precursors generate lung dendritic cells during respiratory viral infection, but are depleted in the process. J. Immunol., 2006, 177, 2536-2542 (Pubitemid 44201012)
196. Voges, B.; Vallbracht, S.; Zimmer, G.; Bossow, S.; Neubert, W.J.; Richter, K.; Hobeika, E.; Herrler, G.; Ehl, S. Recombinant Sendai virus induces T cell immunity against respiratory syncytial virus that is protective in the absence of antibodies. Cell. Immunol., 2007, 247, 85-94. (Pubitemid 350019448)
197. Hsu, S.C.; Chargelegue, D.; Obeid, O.E.; Steward, M.W. Synergistic effect of immunization with a peptide cocktail inducing antibody, helper and cytotoxic T-cell responses on protection against respiratory syncytial virus. J. Gen. Virol., 1999, 80(Pt 6), 1401-1405
198. Elliott, M.B.; Chen, T.; Terio, N.B.; Chong, S.Y.; Abdullah, R.; Luckay, A.; Egan, M.A.; Boutilier, L.A.; Melville, K.; Lerch, R.A.; Long, D.; Eldridge, J.H.; Parks, C.L.; Udem, S.A.; Hancock, G.E. Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques. Vaccine, 2007, 25, 7132-7144
199. Fu, Y.; He, J.; Zheng, X.; Wu, Q.; Zhang, M.; Wang, X.; Wang, Y.; Xie, C.; Tang, Q.; Wei, W.; Wang, M.; Song, J.; Qu, J.; Zhang, Y.; Hong, T. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice. Biochem. Biophys. Res. Commun., 2009, 381, 528-532
200. Lin, Y.H.; Deatly, A.M.; Chen, W.; Miller, L.Z.; Lerch, R.; Sidhu, M.S.; Udem, S.A.; Randolph, V.B. Genetic stability determinants of temperature sensitive, live attenuated respiratory syncytial virus vaccine candidates. Virus Res., 2006, 115, 9-15.
201. Collins, P.L.; Murphy, B.R. New generation live vaccines against human respiratory syncytial virus designed by reverse genetics. Proc. Am. Thorac. Soc., 2005, 2, 166-173
202. Juhasz, K.; Whitehead, S.S.; Bui, P.T.; Biggs, J.M.; Crowe, J.E.; Boulanger, C.A.; Collins, P.L.; Murphy, B.R. The temperaturesensitive (ts) phenotype of a cold-passaged (cp) live attenuated respiratory syncytial virus vaccine candidate, designated cpts530, results from a single amino acid substitution in the L protein. J. Virol., 1997, 71, 5814-5819 (Pubitemid 27304917)
203. Teng, M.N.; Whitehead, S.S.; Collins, P.L. Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo. Virology, 2001, 289, 283-296
204. Connors, M.; Crowe, J.E., Jr.; Firestone, C.Y.; Murphy, B.R.; Collins, P.L. A cold-passaged, attenuated strain of human respiratory syncytial virus contains mutations in the F and L genes. Virology, 1995, 208, 478-484
205. Elliott, M.B.; Pryharski, K.S.; Yu, Q.; Boutilier, L.A.; Campeol, N.; Melville, K.; Laughlin, T.S.; Gupta, C.K.; Lerch, R.A.; Randolph, V.B.; LaPierre, N.A.; Dack, K.M.; Hancock, G.E. Characterization of recombinant respiratory syncytial viruses with the region responsible for type 2 T-cell responses and pulmonary eosinophilia deleted from the attachment (G) protein. J. Virol., 2004, 78, 8446-8454
206. Elliott, M.B.; Pryharski, K.S.; Yu, Q.; Parks, C.L.; Laughlin, T.S.; Gupta, C.K.; Lerch, R.A.; Randolph, V.B.; LaPierre, N.A.; Dack, K.M.; Hancock, G.E. Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitro. J. Virol., 2004, 78, 5773-5783
207. Bukreyev, A.; Belyakov, I.M.; Berzofsky, J.A.; Murphy, B.R.; Collins, P.L. Granulocyte-macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigenpresenting cells. J. Virol., 2001, 75, 12128-12140
208. Bukreyev, A.; Whitehead, S.S.; Prussin, C.; Murphy, B.R.; Collins, P.L. Effect of coexpression of interleukin-2 by recombinant respiratory syncytial virus on virus replication, immunogenicity, and production of other cytokines. J. Virol., 2000, 74, 7151-7157
209. Collins, P.L.; Purcell, R.H.; London, W.T.; Lawrence, L.A.; Chanock, R.M.; Murphy, B.R. Evaluation in chimpanzees of vaccinia virus recombinants that express the surface glycoproteins of human respiratory syncytial virus. Vaccine, 1990, 8, 164-168
210. de Waal, L.; Wyatt, L.S.; Yuksel, S.; van Amerongen, G.; Moss, B.; Niesters, H.G.; Osterhaus, A.D.; de Swart, R.L. Vaccination of infant macaques with a recombinant modified vaccinia virus Ankara expressing the respiratory syncytial virus F and G genes does not predispose for immunopathology. Vaccine, 2004, 22, 923-926
211. Takimoto, T.; Hurwitz, J.L.; Coleclough, C.; Prouser, C.; Krishnamurthy, S.; Zhan, X.; Boyd, K.; Scroggs, R.A.; Brown, B.; Nagai, Y.; Portner, A.; Slobod, K.S. Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV. J. Virol., 2004, 78, 6043-6047
212. Zhan, X.; Hurwitz, J.L.; Krishnamurthy, S.; Takimoto, T.; Boyd, K.; Scroggs, R.A.; Surman, S.; Portner, A.; Slobod, K.S. Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B. Vaccine, 2007, 25, 8782-8793
213. Cyr, S.L.; Jones, T.; Stoica-Popescu, I.; Brewer, A.; Chabot, S.; Lussier, M.; Burt, D.; Ward, B.J. Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology. Vaccine, 2007, 25, 5378-5389
214. Etchart, N.; Baaten, B.; Andersen, S.R.; Hyland, L.; Wong, S.Y.; Hou, S. Intranasal immunisation with inactivated RSV and bacterial adjuvants induces mucosal protection and abrogates eosinophilia upon challenge. Eur. J. Immunol., 2006, 36, 1136-1144
215. Prince, G.A.; Mond, J.J.; Porter, D.D.; Yim, K.C.; Lan, S.J.; Klinman, D.M. Immunoprotective activity and safety of a respiratory syncytial virus vaccine: mucosal delivery of fusion glycoprotein with a CpG oligodeoxynucleotide adjuvant. J. Virol., 2003, 77, 13156-13160
216. Huang, Y.; Anderson, R. Modulation of protective immunity, eosinophilia, and cytokine responses by selective mutagenesis of a recombinant G protein vaccine against respiratory syncytial virus. J. Virol., 2005, 79, 4527-4532 (Pubitemid 40388391)
217. Kim, H.J.; Kim, J.K.; Seo, S.B.; Lee, H.J. Intranasal vaccination with peptides and cholera toxin subunit B as adjuvant to enhance mucosal and systemic immunity to respiratory syncytial virus. Arch. Pharm. Res., 2007, 30, 366-371
218. Zeng, R.; Zhang, Z.; Mei, X.; Gong, W.; Wei, L. Protective effect of a RSV subunit vaccine candidate G1F/M2 was enhanced by a HSP70-Like protein in mice. Biochem. Biophys. Res. Commun., 2008, 377, 495-499
219. Hu, K.F.; Regner, M.; Siegrist, C.A.; Lambert, P.; Chen, M.; Bengtsson, K.L.; Morein, B. The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP703. FEMS Immunol. Med. Microbiol., 2005, 43, 269-276 (Pubitemid 40170297)
220. Helson, R.; Olszewska, W.; Singh, M.; Megede, J.Z.; Melero, J.A.; O'Hagan, D.; Openshaw, P.J. Polylactide-co-glycolide (PLG) microparticles modify the immune response to DNA vaccination. Vaccine, 2008, 26, 753-761
221. Mottram, P.L.; Leong, D.; Crimeen-Irwin, B.; Gloster, S.; Xiang, S.D.; Meanger, J.; Ghildyal, R.; Vardaxis, N.; Plebanski, M. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus. Mol. Pharm., 2007, 4, 73-84. (Pubitemid 46302130)
222. Hancock, G.E.; Heers, K.M.; Pryharski, K.S.; Smith, J.D.; Tiberio, L. Adjuvants recognized by toll-like receptors inhibit the induction of polarized type 2 T cell responses by natural attachment (G) protein of respiratory syncytial virus. Vaccine, 2003, 21, 4348-4358 (Pubitemid 37130276)
223. Zhang, W.; Tripp, R.A. RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response. J. Virol., 2008, 82, 12221-12231
224. Barik, S. Treating respiratory viral diseases with chemically modified, second generation intranasal siRNAs. Methods Mol. Biol., 2009, 487, 331-341
225. DeVincenzo, J.P. RNA interference strategies as therapy for respiratory viral infections. Pediatr. Infect. Dis. J., 2008, 27, S118-22.
226. DeVincenzo, J.; Cehelsky, J.E.; Alvarez, R.; Elbashir, S.; Harborth, J.; Toudjarska, I.; Nechev, L.; Murugaiah, V.; Van Vliet, A.; Vaishnaw, A.K.; Meyers, R. Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV). Antiviral. Res., 2008, 77, 225-231
227. Falsey, A.R.; Walsh, E.E.; Capellan, J.; Gravenstein, S.; Zambon, M.; Yau, E.; Gorse, G.J.; Edelman, R.; Hayden, F.G.; McElhaney, J.E.; Neuzil, K.M.; Nichol, K.L.; Simoes, E.A.; Wright, P.F.; Sales, V.M. Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines-- nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals. J. Infect. Dis., 2008, 198, 1317-1326
228. Crowe, J.E., Jr.; Randolph, V.; Murphy, B.R. The live attenuated subgroup B respiratory syncytial virus vaccine candidate RSV 2B33F is attenuated and immunogenic in chimpanzees, but exhibits partial loss of the ts phenotype following replication in vivo. Virus Res., 1999, 59, 13-22.
229. Xie, C.; He, J.S.; Zhang, M.; Xue, S.L.; Wu, Q.; Ding, X.D.; Song, W.; Yuan, Y.; Li, D.L.; Zheng, X.X.; Lu, Y.Y.; Shang, Z. Oral respiratory syncytial virus (RSV) DNA vaccine expressing RSV F protein delivered by attenuated Salmonella typhimurium. Hum. Gene Ther., 2007, 18, 746-752 (Pubitemid 47378071)
230. Goetsch, L.; Gonzalez, A.; Plotnicky-Gilquin, H.; Haeuw, J.F.; Aubry, J.P.; Beck, A.; Bonnefoy, J.Y.; Corvaia, N. Targeting of nasal mucosa-associated antigen-presenting cells in vivo with an outer membrane protein A derived from Klebsiella pneumoniae. Infect. Immun, 2001, 69, 6434-6444 (Pubitemid 32885209)
231. Cainelli Gebara, V.C.; Risoleo, L.; Lopes, A.P.; Ferreira, V.R.; Quintilio, W.; Lepine, F.; Silva, W.D.; Raw, I. Adjuvant and immunogenic activities of the 73kDa N-terminal alpha-domain of BrkA autotransporter and Cpn60/60kDa chaperonin of Bordetella pertussis. Vaccine, 2007, 25, 621-629
232. Buhler, O.T.; Wiedig, C.A.; Schmid, Y.; Grassl, G.A.; Bohn, E.; Autenrieth, I.B. The Yersinia enterocolitica invasin protein promotes major histocompatibility complex class I- and class II-restricted T-cell responses. Infect. Immun., 2006, 74, 4322-4329
233. Lee, S.E.; Kim, S.Y.; Jeong, B.C.; Kim, Y.R.; Bae, S.J.; Ahn, O.S.; Lee, J.J.; Song, H.C.; Kim, J.M.; Choy, H.E.; Chung, S.S.; Kweon, M.N.; Rhee, J.H. A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity. Infect. Immun., 2006, 74, 694-702.
234. Yigang, X.U.; Yijing, L.I. Construction of recombinant Lactobacillus casei efficiently surface displayed and secreted porcine parvovirus VP2 protein and comparison of the immune responses induced by oral immunization. Immunology, 2008, 124, 68-75.
235. Mohamadzadeh, M.; Duong, T.; Hoover, T.; Klaenhammer, T.R. Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria. Expert Rev. Vaccines, 2008, 7, 163-174
236. Kotton, C.N.; Hohmann, E.L. Enteric pathogens as vaccine vectors for foreign antigen delivery. Infect. Immun., 2004, 72, 5535-5547
237. Lewis, G.K. Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet? Expert Rev. Vaccines, 2007, 6, 431-440
238. Kwon, Y.M.; Cox, M.M.; Calhoun, L.N. Salmonella-based vaccines for infectious diseases. Expert Rev Vaccines, 2007, 6, 147-152
239. Hernandez-Pando, R.; Castanon, M.; Espitia, C.; Lopez-Vidal, Y. Recombinant BCG vaccine candidates. Curr. Mol. Med., 2007, 7, 365-372
240. Flynn, J.L.; Chan, J. Immunology of tuberculosis. Ann. Rev. Immunol., 2001, 19, 93-129.
241. Hanekom, W.A. The immune response to BCG vaccination of newborns. Ann. NY Acad. Sci., 2005, 1062, 69-78.
242. Marchant, A.; Goetghebuer, T.; Ota, M.O.; Wolfe, I.; Ceesay, S.J.; De Groote, D.; Corrah, T.; Bennett, S.; Wheeler, J.; Huygen, K.; Aaby, P.; McAdam, K.P.; Newport, M.J. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J. Immunol., 1999, 163, 2249-2255
243. Fennelly, G.J.; Flynn, J.L.; ter Meulen, V.; Liebert, U.G.; Bloom, B.R. Recombinant bacille Calmette-Guerin priming against measles. J. Infect. Dis., 1995, 172, 698-705.
244. Dennehy, M.; Bourn, W.; Steele, D.; Williamson, A.L. Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine. Vaccine, 2007, 25, 3646-3657
245. Rapeah, S.; Norazmi, M.N. Immunogenicity of a recombinant Mycobacterium bovis bacille Calmette-Guerin expressing malarial and tuberculosis epitopes. Vaccine, 2006, 24, 3646-3653
246. Medeiros, M.A.; Armoa, G.R.; Dellagostin, O.A.; McIntosh, D. Induction of humoral immunity in response to immunization with recombinant Mycobacterium bovis BCG expressing the S1 subunit of Bordetella pertussis toxin. Can. J. Microbiol., 2005, 51, 1015-1020 (Pubitemid 43363059)
247. Cayabyab, M.J.; Hovav, A.H.; Hsu, T.; Krivulka, G.R.; Lifton, M.A.; Gorgone, D.A.; Fennelly, G.J.; Haynes, B.F.; Jacobs, W.R., Jr.; Letvin, N.L. Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env. J. Virol., 2006, 80, 1645-1652 (Pubitemid 43228706)
248. Kawahara, M.; Matsuo, K.; Honda, M. Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs. Clin. Immunol., 2006, 119, 67-78.
249. Im, E.J.; Saubi, N.; Virgili, G.; Sander, C.; Teoh, D.; Gatell, J.M.; McShane, H.; Joseph, J.; Hanke, T.; Vaccine platform for prevention of tuberculosis and mother-to-child transmission of human immunodeficiency virus type 1 through breastfeeding. J. Virol., 2007, 81, 9408-9418 (Pubitemid 47311483)
250. Rezende, C.A.; De Moraes, M.T.; De Souza Matos, D.C.; McIntoch, D.; Armoa, G.R. Humoral response and genetic stability of recombinant BCG expressing hepatitis B surface antigens. J. Virol. Methods, 2005, 125, 1-9.
251. Wang, H.; Liu, Q.; Liu, K.; Zhong, W.; Gao, S.; Jiang, L.; An, N. Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii. Parasitol Int, 2007.